InsiderSignalSign in
← Insider buys

Lewis H Titterton Jr has bought stock on 17 days since Apr 2019

Director at Anixa Biosciences, Inc., and 2 other companies

SEC CIK 0001499254 · Filings on SEC.gov ↗

$2.1MBought
$651KSold
Sep 25Last buy

Lewis H Titterton Jr's record

3 months after each buy, from the first price a copier could get.

+9.5%Average
+7.1 ptsVs S&P 500
8 of 11Higher

11 buys since 2019 with 3 months of prices.

Companies

Every filing

18 filings since Aug 2016, newest first

ANIXBuy

Anixa Biosciences Inc

Director

$132K+4.9%Sep 25
ANIXBuy

Anixa Biosciences Inc

Director

$27K+1.0%Sep 14
ANIXBuy

Anixa Biosciences Inc

Director

$42K+1.2%Jul 20
PRKRBuy

Parkervision Inc

Director

$1.0M+125.0%Nov 18
ANIXBuy

Anixa Biosciences Inc

Director

$31K+1.0%Aug 4
ANIXBuy

Anixa Biosciences Inc

Director

$31K+1.0%Jul 15
ANIXBuy

Anixa Biosciences Inc

Director

$26K+1.0%Jan 17
ANIXBuy

Anixa Biosciences Inc

Director

$84K+3.0%Aug 1
ANIXBuy

Anixa Biosciences Inc

Director

$26K+1.0%Jul 29
ANIXBuy

Anixa Biosciences Inc

Director

$27K+1.0%Jun 10
ANIXBuy

Anixa Biosciences Inc

Director

$49K+2.0%Apr 10
ANIXBuy

Anixa Biosciences Inc

Director

$28K+1.0%Apr 27
ANIXBuy

Anixa Biosciences Inc

Director

$34K+1.0%Jan 10
ANIXBuy

Anixa Biosciences Inc

Director

$87K+2.0%Nov 1
ANIXBuy

Anixa Biosciences Inc

Director

$218K+5.0%Mar 26
ANIXBuy

Anixa Biosciences Inc

Director

$62K+2.0%Sep 16
ANIXBuy

Anixa Biosciences Inc

Director

$205K+6.0%Apr 22
ITUSSell

Itus Corp

Director

$651K−42.0%Aug 26
About Lewis H Titterton Jr

Lewis H. Titterton Jr. is an independent director of ParkerVision Inc. (PRKR), where he owns approximately 8,578,170 shares valued at over $2 million as of 2026.( He rejoined the board following a previous tenure from September 2018 to April 2019, during which he resigned due to family medical issues.(

Titterton has demonstrated significant commitment to ParkerVision through recent insider transactions, including a $1 million private equity purchase of 4,761,905 shares.( His latest Schedule 13D filing on November 20, 2025, reports ownership of 8.83 million shares, underscoring his substantial stake in the company.( Detailed career highlights and education are not specified in available sources.

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.